IDH1 and central nervous system neoplasm: The current WHO classification system for CNS tumors incorporates common genetic alterations, and diffuse gliomas are classified based on the presence or absence of mutations in the metabolic enzyme Isocitrate Dehydrogenase (IDH), the most common being IDH1-R132H [1].